![Inside Honeywell’s plan for a new F-35 cooling system [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/07/8509355-1-scaled-e1721820217290.jpg?#)
Insmed surges on lung drug data; Recursion cuts staff
Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations. Elsewhere, Recursion is laying off 20% of its workforce and Gilead halted several HIV studies.
Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations. Elsewhere, Recursion is laying off 20% of its workforce and Gilead halted several HIV studies.
